Federal Register
Notice: FDA is making available a guidance for industry entitled Chronic Cutaneous Ulcer and Burn Wounds — Developing Products for Treatment. It provides recommendations on developing products for the treatment of chronic cutaneous ulcer and burn wounds, including general guidance on clinical trial design and preclinical and manufacturing considerations. The document finalizes a 6/28/00 draft guidance. To view this notice, click here.